文献速递糖尿病性腺与生殖内分泌

1型糖尿病合并勃起功能障碍男性的小纤维神经病变:一项横断面研究

Small-fibre neuropathy in men with type 1 diabetes and erectile dysfunction: a cross-sectional study.
PubMed 文献 · Diabetologia · 2017-03-29

该横断面研究纳入70例1型糖尿病男性(29例无勃起功能障碍、41例有勃起功能障碍)及34名年龄匹配对照,全面评估大、小纤维神经病变。1型糖尿病者勃起功能障碍患病率为58.6%。校正年龄后,合并勃起功能障碍者神经病变症状评分更高、振动感知阈值更高、腓肠神经和腓总神经振幅更低、腓总神经传导速度更慢,并存在明显小纤维神经病变(冷、温阈值受损、心率变异性降低、表皮内神经纤维密度及角膜神经纤维密度、分支密度、长度均降低),勃起功能障碍与大、小纤维神经病变指标均显著相关。结论认为小纤维神经病变在1型糖尿病中突出,与勃起功能障碍相关,可用角膜共聚焦显微镜客观量化,或有助于识别对磷酸二酯酶5抑制剂等常规治疗反应不佳的患者。

要点

  • 1型糖尿病男性勃起功能障碍患病率为58.6%。
  • 合并勃起功能障碍者校正年龄后大纤维神经病变指标更差。
  • 合并勃起功能障碍者存在明显小纤维神经病变。

核心结论

  • 小纤维神经病变在1型糖尿病患者中突出,与勃起功能障碍相关,并可用角膜共聚焦显微镜客观量化。
  • 作者认为这可能有助于识别对磷酸二酯酶5抑制剂等常规治疗反应不佳的患者。

研究设计与样本

  • 横断面研究,纳入70例1型糖尿病男性(29例无勃起功能障碍、41例有勃起功能障碍)及34名年龄匹配对照。
  • 所有参与者接受大纤维和小纤维神经病变的全面评估。

主要发现

  • 1型糖尿病参与者中勃起功能障碍患病率为58.6%。
  • 校正年龄后,合并勃起功能障碍者神经病变症状评分(Neuropathy Symptom Profile)均值±标准误为5.3±0.9 vs 无勃起功能障碍者1.8±1.2,p=0.03。
  • 校正年龄后,合并勃起功能障碍者振动感知阈值为18.3±1.9 V vs 无勃起功能障碍者10.7±2.4 V,p=0.02。
  • 校正年龄后,合并勃起功能障碍者腓肠神经振幅为5.0±1.1 mV vs 无勃起功能障碍者11.7±1.5 mV,p=0.002;腓总神经振幅为2.1±0.4 mV vs 4.7±0.5 mV,p<0.001;腓总神经传导速度为34.8±1.5 m/s vs 41.9±2.0 m/s,p=0.01。
  • 校正年龄后,合并勃起功能障碍者冷阈值为19.7±1.4°C vs 无勃起功能障碍者27.3±1.8°C,p=0.003;温阈值为42.9±0.8°C vs 39.0±0.9°C,p=0.005;心率变异性为21.5±3.1 vs 30.0±3.7 次/分,p=0.001;表皮内神经纤维密度为2.8±0.7 vs 5.9±0.7/mm,p=0.008;角膜神经纤维密度为12.6±1.5 vs 23.9±2.0/mm²,p<0.001;角膜神经分支密度为12.7±2.5 vs 31.6±3.3/mm²,p<0.001;角膜神经纤维长度为8.3±0.7 vs 14.5±1.0 mm/mm²,p<0.001。

关键数值与推荐

  • 1型糖尿病参与者中勃起功能障碍患病率为58.6%。
  • 合并勃起功能障碍者神经病变症状评分均值±标准误为5.3±0.9 vs 无勃起功能障碍者1.8±1.2,p=0.03。
  • 合并勃起功能障碍者振动感知阈值为18.3±1.9 V vs 无勃起功能障碍者10.7±2.4 V,p=0.02。
  • 合并勃起功能障碍者腓肠神经振幅为5.0±1.1 mV vs 无勃起功能障碍者11.7±1.5 mV,p=0.002。
  • 合并勃起功能障碍者腓总神经振幅为2.1±0.4 mV vs 4.7±0.5 mV,p<0.001;腓总神经传导速度为34.8±1.5 m/s vs 41.9±2.0 m/s,p=0.01。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of this study was to identify the contribution of small- and large-fibre neuropathy to erectile dysfunction in men with type 1 diabetes mellitus. METHODS: A total of 70 participants (29 without and 41 with erectile dysfunction) with type 1 diabetes and 34 age-matched control participants underwent a comprehensive assessment of large- and small-fibre neuropathy. RESULTS: The prevalence of erectile dysfunction in participants with type 1 diabetes was 58.6%. After adjusting for age, participants with type 1 diabetes and erectile dysfunction had a significantly higher score on the Neuropathy Symptom Profile (mean ± SEM 5.3 ± 0.9 vs 1.8 ± 1.2, p = 0.03), a higher vibration perception threshold (18.3 ± 1.9 vs 10.7 ± 2.4 V, p = 0.02), and a lower sural nerve amplitude (5.0 ± 1.1 vs 11.7 ± 1.5 mV, p = 0.002), peroneal nerve amplitude (2.1 ± 0.4 vs 4.7 ± 0.5 mV, p < 0.001) and peroneal nerve conduction velocity (34.8 ± 1.5 vs 41.9 ± 2.0 m/s, p = 0.01) compared with those without erectile dysfunction. There was also evidence of a marked small-fibre neuropathy with an impaired cold threshold (19.7 ± 1.4°C vs 27.3 ± 1.8°C, p = 0.003), warm threshold (42.9 ± 0.8°C vs 39.0 ± 0.9°C, p = 0.005) and heart rate variability (21.5 ± 3.1 vs 30.0 ± 3.7 beats/min, p = 0.001) and reduced intraepidermal nerve fibre density (2.8 ± 0.7 vs 5.9 ± 0.7/mm, p = 0.008), corneal nerve fibre density (12.6 ± 1.5 vs 23.9 ± 2.0/mm2, p < 0.001), corneal nerve branch density (12.7 ± 2.5 vs 31.6 ± 3.3/mm2, p < 0.001) and corneal nerve fibre length (8.3 ± 0.7 vs 14.5 ± 1.0 mm/mm2, p < 0.001) in participants with type 1 diabetes and erectile dysfunction. Erectile dysfunction correlated significantly with measures of both large- and small-fibre neuropathy. CONCLUSIONS/INTERPRETATION: Small-fibre neuropathy is prominent in patients with type 1 diabetes, and is associated with erectile dysfunction and can be objectively quantified using corneal confocal microscopy. This may allow the identification of patients who are less likely to respond to conventional therapies such as phosphodiesterase type 5 inhibitors.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Azmi S, Ferdousi M, Alam U, et al. Small-fibre neuropathy in men with type 1 diabetes and erectile dysfunction: a cross-sectional study. Diabetologia. 2017. PMID: 28357503. doi:10.1007/s00125-017-4245-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。